Viewing Study NCT05226533


Ignite Creation Date: 2025-12-25 @ 3:01 AM
Ignite Modification Date: 2026-05-05 @ 2:59 PM
Study NCT ID: NCT05226533
Status: TERMINATED
Last Update Posted: 2023-02-10
First Post: 2022-02-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.
Sponsor: Daewoong Pharmaceutical Co. LTD.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: DW_DWJ1516202
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators